EP Patent

EP1170353A2 — Liquid crystal composition comprising liquid crystal molecules and aligment promoter

Assigned to Fujifilm Holdings Corp · Expires 2002-01-09 · 24y expired

What this patent protects

A liquid crystal composition comprises liquid crystal molecules and an alignment promoter. The alignment promoter is represented by the formula (I). (Hb-L<l>-)nBl In the formula (I), Hb is an aliphatic group having 4 to 40 carbon atoms, an aromatic group having 6 to 40 carb…

USPTO Abstract

A liquid crystal composition comprises liquid crystal molecules and an alignment promoter. The alignment promoter is represented by the formula (I). (Hb-L<l>-)nBl In the formula (I), Hb is an aliphatic group having 4 to 40 carbon atoms, an aromatic group having 6 to 40 carbon atoms or an aliphatic substituted oligosiloxanoxy group having 1 to 40 carbon atoms. L<1> is a single bond or a divalent linking group, and n is an integer of 2 to 12. Bl is an n-valent group comprising at least two rings.

Drugs covered by this patent

Patent Metadata

Patent number
EP1170353A2
Jurisdiction
EP
Classification
—
Expires
2002-01-09
Drug substance claim
No
Drug product claim
No
Assignee
Fujifilm Holdings Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.